BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 28103946)

  • 1. EPCR promotes breast cancer progression by altering SPOCK1/testican 1-mediated 3D growth.
    Perurena N; Zandueta C; Martínez-Canarias S; Moreno H; Vicent S; Almeida AS; Guruceaga E; Gomis RR; Santisteban M; Egeblad M; Hermida J; Lecanda F
    J Hematol Oncol; 2017 Jan; 10(1):23. PubMed ID: 28103946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SPOCK1 as a potential cancer prognostic marker promotes the proliferation and metastasis of gallbladder cancer cells by activating the PI3K/AKT pathway.
    Shu YJ; Weng H; Ye YY; Hu YP; Bao RF; Cao Y; Wang XA; Zhang F; Xiang SS; Li HF; Wu XS; Li ML; Jiang L; Lu W; Han BS; Jie ZG; Liu YB
    Mol Cancer; 2015 Jan; 14(1):12. PubMed ID: 25623055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plakophilin 1-deficient cells upregulate SPOCK1: implications for prostate cancer progression.
    Yang C; Fischer-Kešo R; Schlechter T; Ströbel P; Marx A; Hofmann I
    Tumour Biol; 2015 Dec; 36(12):9567-77. PubMed ID: 26138584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SPOCK1 is a novel transforming growth factor-β target gene that regulates lung cancer cell epithelial-mesenchymal transition.
    Miao L; Wang Y; Xia H; Yao C; Cai H; Song Y
    Biochem Biophys Res Commun; 2013 Nov; 440(4):792-7. PubMed ID: 24134845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting the SPOCK1-snail/slug axis-mediated epithelial-to-mesenchymal transition by apigenin contributes to repression of prostate cancer metastasis.
    Chien MH; Lin YW; Wen YC; Yang YC; Hsiao M; Chang JL; Huang HC; Lee WJ
    J Exp Clin Cancer Res; 2019 Jun; 38(1):246. PubMed ID: 31182131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SPOCK1 promotes tumor growth and metastasis in human prostate cancer.
    Chen Q; Yao YT; Xu H; Chen YB; Gu M; Cai ZK; Wang Z
    Drug Des Devel Ther; 2016; 10():2311-21. PubMed ID: 27486308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SPOCK1 is regulated by CHD1L and blocks apoptosis and promotes HCC cell invasiveness and metastasis in mice.
    Li Y; Chen L; Chan TH; Liu M; Kong KL; Qiu JL; Li Y; Yuan YF; Guan XY
    Gastroenterology; 2013 Jan; 144(1):179-191.e4. PubMed ID: 23022495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Knockdown of SPOCK1 Inhibits the Proliferation and Invasion in Colorectal Cancer Cells by Suppressing the PI3K/Akt Pathway.
    Zhao P; Guan HT; Dai ZJ; Ma YG; Liu XX; Wang XJ
    Oncol Res; 2016 Oct; 24(6):437-445. PubMed ID: 28281964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SPOCK1 Is a Novel Transforming Growth Factor-β-Induced Myoepithelial Marker That Enhances Invasion and Correlates with Poor Prognosis in Breast Cancer.
    Fan LC; Jeng YM; Lu YT; Lien HC
    PLoS One; 2016; 11(9):e0162933. PubMed ID: 27626636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SPOCK1 promotes the proliferation, migration and invasion of glioma cells through PI3K/AKT and Wnt/β-catenin signaling pathways.
    Yang J; Yang Q; Yu J; Li X; Yu S; Zhang X
    Oncol Rep; 2016 Jun; 35(6):3566-76. PubMed ID: 27108836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SPOCK1 promotes metastasis in pancreatic cancer via NF-κB-dependent epithelial-mesenchymal transition by interacting with IκB-α.
    Cui X; Wang Y; Lan W; Wang S; Cui Y; Zhang X; Lin Z; Piao J
    Cell Oncol (Dordr); 2022 Feb; 45(1):69-84. PubMed ID: 34855159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteoglycan SPOCK1 as a Poor Prognostic Marker Promotes Malignant Progression of Clear Cell Renal Cell Carcinoma via Triggering the Snail/Slug-MMP-2 Axis-Mediated Epithelial-to-Mesenchymal Transition.
    Lin YW; Wen YC; Hsiao CH; Lai FR; Yang SF; Yang YC; Ho KH; Hsieh FK; Hsiao M; Lee WJ; Chien MH
    Cells; 2023 Jan; 12(3):. PubMed ID: 36766694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stromal SPOCK1 supports invasive pancreatic cancer growth.
    Veenstra VL; Damhofer H; Waasdorp C; Steins A; Kocher HM; Medema JP; van Laarhoven HW; Bijlsma MF
    Mol Oncol; 2017 Aug; 11(8):1050-1064. PubMed ID: 28486750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ets-1 controls breast cancer cell balance between invasion and growth.
    Furlan A; Vercamer C; Bouali F; Damour I; Chotteau-Lelievre A; Wernert N; Desbiens X; Pourtier A
    Int J Cancer; 2014 Nov; 135(10):2317-28. PubMed ID: 24706481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SPOCK1/SIX1axis promotes breast cancer progression by activating AKT/mTOR signaling.
    Xu M; Zhang X; Zhang S; Piao J; Yang Y; Wang X; Lin Z
    Aging (Albany NY); 2020 Dec; 13(1):1032-1050. PubMed ID: 33293473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Receptor of activated protein C promotes metastasis and correlates with clinical outcome in lung adenocarcinoma.
    Antón I; Molina E; Luis-Ravelo D; Zandueta C; Valencia K; Ormazabal C; Martínez-Canarias S; Perurena N; Pajares MJ; Agorreta J; Montuenga LM; Segura V; Wistuba II; De Las Rivas J; Hermida J; Lecanda F
    Am J Respir Crit Care Med; 2012 Jul; 186(1):96-105. PubMed ID: 22461368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cleaved CD44 intracellular domain supports activation of stemness factors and promotes tumorigenesis of breast cancer.
    Cho Y; Lee HW; Kang HG; Kim HY; Kim SJ; Chun KH
    Oncotarget; 2015 Apr; 6(11):8709-21. PubMed ID: 25909162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TRAIL-R2 promotes skeletal metastasis in a breast cancer xenograft mouse model.
    Fritsche H; Heilmann T; Tower RJ; Hauser C; von Au A; El-Sheikh D; Campbell GM; Alp G; Schewe D; Hübner S; Tiwari S; Kownatzki D; Boretius S; Adam D; Jonat W; Becker T; Glüer CC; Zöller M; Kalthoff H; Schem C; Trauzold A
    Oncotarget; 2015 Apr; 6(11):9502-16. PubMed ID: 25909161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced SPOCK1 expression inhibits non-small cell lung cancer cell proliferation and migration through Wnt/β-catenin signaling.
    Wang T; Liu X; Tian Q; Liang T; Chang P
    Eur Rev Med Pharmacol Sci; 2018 Feb; 22(3):637-644. PubMed ID: 29461591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infiltrating S100A8+ myeloid cells promote metastatic spread of human breast cancer and predict poor clinical outcome.
    Drews-Elger K; Iorns E; Dias A; Miller P; Ward TM; Dean S; Clarke J; Campion-Flora A; Rodrigues DN; Reis-Filho JS; Rae JM; Thomas D; Berry D; El-Ashry D; Lippman ME
    Breast Cancer Res Treat; 2014 Nov; 148(1):41-59. PubMed ID: 25270120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.